Cite

    Tiffany, C. et al. (2022). Pharmacokinetics, safety, and tolerability of gepotidacin administered as single or repeat ascending doses, in healthy adults and elderly subjects. Clinical and translational science. 15 (9), pp. 2251-2264. [Online].